Pharmaceutical Products (Medicines for Dermatological and Musculoskeletal Diseases)

This tender concerns the procurement of pharmaceutical products, specifically medicines intended for the treatment of dermatological and musculoskeletal conditions. The procurement process will be conducted in accordance with the specific procedures outlined in the Resolution of the Cabinet of Ministers of Ukraine No. 1178 dated October 12, 2022, as amended, utilizing the electronic catalog system.

The primary requirement is the supply of goods within three working days from the moment a request is received, and in the quantities specified in the request sent to the supplier. A crucial condition is that the country of origin for the supplied goods cannot be the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran.

The specified items include Ketorolac solution for injection (30 mg/ml, 1 ml vials), Ketorolac tablets coated with a film shell (10 mg), and Nimesulide granules (powder) for oral suspension (100 mg/2 g, 2 g sachets). The tender also lists Decamethoxin tablets (0.2 mg). All listed items fall under the CPV code 33630000-5, which pertains to pharmaceutical preparations. This procurement aims to ensure the availability of essential medications for patients suffering from relevant conditions, adhering to strict delivery timelines and origin restrictions.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 31,330.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.